TimothyCNicholsMD
Cardiology • Chapel Hill, NCInterventional Cardiology
Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Nichols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4996Fax+1 919-843-5515
Education & Training
University of North Carolina HospitalsFellowship, Cardiovascular Disease, 1982 - 1985- University of North Carolina HospitalsResidency, Internal Medicine, 1978 - 1982
Virginia Commonwealth University School of MedicineClass of 1978
Certifications & Licensure
NC State Medical License 1978 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 7 citationsDexamethasone transiently enhances transgene expression in the liver when administered at late phase post long term AAV transduction.Zheng Chai, Xintao Zhang, Amanda Lee Dobbins, R. Jude Samulski, Elizabeth P. Merricks
Human Gene Therapy. 2021-10-07 - 7 citationsCombination of Nitric Oxide Release and Surface Texture for Mitigating the Foreign Body Response.Maggie J Malone-Povolny, Taron M Bradshaw, Elizabeth P. Merricks, C. Tyler Long, Timothy C. Nichols
ACS Biomaterials Science & Engineering. 2021-04-13 - 11 citationsEvolutionary insights into coagulation factor IX Padua and other high-specific-activity variantsBenjamin J. Samelson-Jones, Jonathan D. Finn, Leslie Raffini, Elizabeth P. Merricks, Rodney M. Camire
Blood Advances. 2021-03-09
Abstracts/Posters
- Hemophilia A Dogs Tolerant to Human Factor VIII Provide a Unique Model to Determine Efficacy and Safety of AAV Delivery of Novel Factor VIII VariantsTimothy C. Nichols, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- FVIII Protein Is Not Detectable in Human PBMCs or Livers from Dogs with an Intron-22 Inversion Mutation: Implications for FVIII Immunogenicity and ToleranceTimothy C. Nichols, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
In Crafting New Treatments for Hemophilia, A "Less Is More" ApproachOctober 17th, 2016
Grant Support
- Animal Core For Gene Therapy Of HemophiliaNational Heart, Lung, And Blood Institute2011
- Maintenance Of Animal Models Of Human Hemophilia And VWDNational Heart, Lung, And Blood Institute1999–2011
- Core--CanineNational Heart, Lung, And Blood Institute2005–2009
- Maintenance Of Animal Models Of Human Hemophillia And VWDNational Heart, Lung, And Blood Institute2007
- Maintenance Of Animal Models Of Human Hemophillia &VwdNational Heart, Lung, And Blood Institute2003–2006
- Nf-Kb Activation And Oral Inflammation In AtherogenesisNational Institute Of Dental &Craniofacial Research1999–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
